Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
Open Access
- 17 December 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 4, 367
Abstract
Melanoma cells can switch phenotype in a manner similar to epithelial to mesenchymal transition(EMT). In this perspective article, we address the effects of such phenotype switching on T cell targeting of tumour cells. During the EMT-like switch in phenotype, a concomitant change in expression of multiple tumour antigens occurs. Melanoma cells undergoing EMT escape from killing by T cells specific for antigens whose expression is downregulated by this process. We discuss melanoma antigens whose expression is influenced by EMT. We assess the effect of changes in the expressed tumour antigen repertoire on T cell mediated tumour recognition and killing. In addition to escape from T cell immunity via changes in antigen expression, mesenchymal-like melanoma cells are generally more resistant to classical chemotherapy and radiotherapy. However, we demonstrate that when targeting antigens whose expression is unaltered during EMT, the capacity of T cells to kill melanoma cell lines in vitro is not influenced by their phenotype. When considering immune therapies such as cancer vaccination, these data suggest escape from T cell killing due to phenotype switching in melanoma could potentially be avoided by careful selection of target antigenKeywords
This publication has 30 references indexed in Scilit:
- Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanomaOncotarget, 2014
- The Ludwig Institute for Cancer Research Melbourne Melanoma Cell Line PanelPigment Cell & Melanoma Research, 2013
- Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in MelanomaCancer Discovery, 2013
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified PeptidesClinical Cancer Research, 2012
- Epithelial-Mesenchymal-Transition-Like and TGFβ Pathways Associated with Autochthonous Inflammatory Melanoma Development in MicePLOS ONE, 2012
- Intra–Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical TrialClinical Cancer Research, 2011
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive StatesCancer Research, 2008
- The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal TransitionJournal of Biological Chemistry, 2007
- A High-Throughput Study in Melanoma Identifies Epithelial-Mesenchymal Transition as a Major Determinant of MetastasisCancer Research, 2007